What's New: Drugs RSS Feed
- Consumer Updates October 19, 2021
- FDA-M CERSI: Analgesic Clinical Trial Designs, Extrapolation, and Endpoints in Patients from Birth to Less Than Two Years of Age Public Workshop - 10/13/2021 - 10/14/2021 October 19, 2021
- Generic Drug Facilities, Sites and Organization Lists October 19, 2021
- GDUFA Paid Facilities List October 19, 2021
- Jon B. Cole, MD - 611902 - 05/05/2021 October 19, 2021
- Lauren R. Klein, MD, M.S. - 605544 - 05/06/2021 October 19, 2021
- Sircle Laboratories, LLC - 615098 - 09/21/2021 October 19, 2021
- Marcus Research Laboratory, Inc. - 615153 - 09/30/2021 October 19, 2021
- AriBio H&B Co., Ltd. - 613107 - 10/08/2021 October 19, 2021
- The Camel Milk Co. LLC dba Camel Culture - 611518 - 09/22/2021 October 19, 2021
What's new
- Involvement of patients in Scientific Advisory Group and Ad Hoc Expert meetings at EMA October 19, 2021
- Involvement of patients in scientific advice procedures at the European Medicines Agency October 19, 2021
- Orphan designation: Palovarotene, Treatment of multiple osteochondromas, 27/06/2018, Withdrawn October 19, 2021
- Orphan designation: Seletalisib, Treatment of activated phosphoinositide 3-kinase delta syndrome, 22/02/2018, Withdrawn October 19, 2021
- Orphan designation: Rozanolixizumab, Treatment of immune thrombocytopenia, 11/01/2019, Positive October 19, 2021
- PRAC work plan 2021 October 19, 2021
- Human medicines European public assessment report (EPAR): Omnitrope, somatropin, Turner Syndrome;Prader-Willi Syndrome;Dwarfism, Pituitary, Date of authorisation: 12/04/2006, Revision: 19, Status: Authorised October 19, 2021